Erratum: Ropivacaine, the N-propyl homologue of bupivacaine [available only as the pure S-(-)-enantiomer], has only recently been introduced for use on children, but the results of preliminary studies suggest that it will probably have a predominant place in paediatrics (CNS Drugs (November 1999) 12:5 (357-368))

G. Ivani, P. De Negri, A. Conio

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)76
Number of pages1
JournalCNS Drugs
Volume13
Issue number1
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Neuropsychology and Physiological Psychology

Cite this